Publication Date:
2014
abstract:
In this issue of Blood, Turesson et al study the risk of progression of monoclonal gammopathy of undetermined significance (MGUS) to lymphoplasmacellular and myeloid malignancies in a large population, validating current risk factors and adding immunoparesis as a predictor of progression.
Iris type:
1.1 Articolo in rivista
Keywords:
Female Hematologic Neoplasms Humans Lymphoma Male Monoclonal Gammopathy of Undetermined Significance Multiple Myeloma
List of contributors:
Merlini, Giampaolo
Published in: